Subscribe
shutterstock_575131204_kenary820
kenary820 / Shutterstock.com
1 September 2022AmericasStaff Writer

AltaThera hits competitor with trade secret suit

Suit claims a contractor used AltaThera secrets to launch a rival heart arrhythmia drug | Chicago-based company wants the court to add its founder as co-inventor on patent.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Navigating the rising wave against non-competes
25 July 2023   Amid criticism against restrictive covenants such as non-competes, what can life sciences firms do to keep their trade secrets safe and defend against unfair competition, ask David Pardue, Patti Bartis, and Sarah Hutchins of Parker Poe.
Big Pharma
Viking Therapeutics accuses Chinese company of trade secret theft
3 January 2023   California-based company alleges competitor stole secrets following a collaboration bid | Complaint says Chinese competitor founded a sister company to develop rival treatment for metabolic disorders.
Big Pharma
Cigna pursues trade secrets in ‘non-competes’ dispute
31 January 2023   Move comes as Federal Trade Commission proposes controversial ban on non-compete clauses | Former executive requested list of “top clients” on day of resignation.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Americas
Navigating the rising wave against non-competes
25 July 2023   Amid criticism against restrictive covenants such as non-competes, what can life sciences firms do to keep their trade secrets safe and defend against unfair competition, ask David Pardue, Patti Bartis, and Sarah Hutchins of Parker Poe.
Big Pharma
Viking Therapeutics accuses Chinese company of trade secret theft
3 January 2023   California-based company alleges competitor stole secrets following a collaboration bid | Complaint says Chinese competitor founded a sister company to develop rival treatment for metabolic disorders.
Big Pharma
Cigna pursues trade secrets in ‘non-competes’ dispute
31 January 2023   Move comes as Federal Trade Commission proposes controversial ban on non-compete clauses | Former executive requested list of “top clients” on day of resignation.

More on this story

Americas
Navigating the rising wave against non-competes
25 July 2023   Amid criticism against restrictive covenants such as non-competes, what can life sciences firms do to keep their trade secrets safe and defend against unfair competition, ask David Pardue, Patti Bartis, and Sarah Hutchins of Parker Poe.
Big Pharma
Viking Therapeutics accuses Chinese company of trade secret theft
3 January 2023   California-based company alleges competitor stole secrets following a collaboration bid | Complaint says Chinese competitor founded a sister company to develop rival treatment for metabolic disorders.
Big Pharma
Cigna pursues trade secrets in ‘non-competes’ dispute
31 January 2023   Move comes as Federal Trade Commission proposes controversial ban on non-compete clauses | Former executive requested list of “top clients” on day of resignation.

More features

President Trump 2.0: Five major areas to watch
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?